ARS Pharmaceuticals, Inc (SPRY) insider trading
Every open-market stock purchase and sale by ARS Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.9M over the last 12 months (4 sales). No open-market buys.
- Last insider buy: Ra Capital Management L.p. (Insider), $5M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.9M (4 sales). Last close $5.67 on Sep 3, 2026.
Recent SPRY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Margaret Ekins Smith (C-suite exec) | Bought (not open market) | — |
| Jun 24, 2026 | Rajeev Dadoo (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Brent L Saunders (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Peter A. Thompson (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Phillip M Schneider (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Laura Shawver (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Saqib Islam (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Michael Kelly (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Pratik Shah (Insider) | Bought (not open market) | — |
| Jun 12, 2026 | Eric Karas (C-suite exec) | Sold | $250K |
| Jun 12, 2026 | Alexander A Fitzpatrick (C-suite exec) | Sold | $33.5K |
| Jun 12, 2026 | Eric Karas (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Kathleen D. Scott (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Eric Karas (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Alexander A Fitzpatrick (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Justin Chakma (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Sarina Tanimoto (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Brian Dorsey (COO) | Bought (not open market) | — |
| Jan 2, 2026 | Sarina Tanimoto (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Richard E Lowenthal (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Richard E Lowenthal (CEO) | Bought (not open market) | — |
| Nov 13, 2025 | Brian Dorsey (COO) | Sold | $190K |
| Nov 13, 2025 | Brian Dorsey (COO) | Bought (not open market) | — |
| Nov 12, 2025 | Justin Chakma (C-suite exec) | Sold | $1.2M |
Who's trading SPRY
- Margaret Ekins Smith, C-suite exec: other filings, last Sep 1, 2026
- Pratik Shah, Insider: other filings, last Jun 24, 2026
- Laura Shawver, Insider: other filings, last Jun 24, 2026
- Peter A. Thompson, Director: other filings, last Jun 24, 2026
- Saqib Islam, Insider: other filings, last Jun 24, 2026
- Phillip M Schneider, Insider: other filings, last Jun 24, 2026
- Ra Capital Management L.p., Insider: other filings, last Jun 24, 2026
- Brent L Saunders, Insider: other filings, last Jun 24, 2026
- Michael Kelly, Insider: other filings, last Jun 24, 2026
- Rajeev Dadoo, Insider: other filings, last Jun 24, 2026
- Eric Karas, C-suite exec: sold $250K (1 sale), last Jun 12, 2026
- Alexander A Fitzpatrick, C-suite exec: sold $33.5K (1 sale), last Jun 12, 2026
- Justin Chakma, C-suite exec: sold $1.5M (2 sales), last Jan 2, 2026
- Brian Dorsey, COO: sold $190K (1 sale), last Jan 2, 2026
- Richard E Lowenthal, CEO: other filings, last Jan 2, 2026
Get free alerts when an insider at ARS Pharmaceuticals, Inc files a new trade →